FHIR IG analytics| Package | lt.hl7.fhir.cvd |
| Resource Type | QuestionnaireResponse |
| Id | QuestionnaireResponse-questionnaireresponse-cvd-prevention-plan-example.json |
| FHIR Version | R5 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
English
Generated Narrative: QuestionnaireResponse questionnaireresponse-cvd-prevention-plan-example
Language: en
| LinkID | Text | Definition | Answer |
|---|---|---|---|
![]() | Questionnaire:Plan of cardiovascular disease prevention measures and achievement evaluation | ||
![]() ![]() | |||
![]() ![]() ![]() | 2025-10-31T10:00:00+02:00 | ||
![]() ![]() ![]() | cvd-questionnaire-options: cvd-rg-very-large (Very large) | ||
![]() ![]() ![]() | cvd-questionnaire-options: ldl-target-18 (<1.8 mmol/l) | ||
![]() ![]() ![]() | |||
![]() ![]() ![]() | cvd-questionnaire-options: cessation-behavior (Behavior change tools) | ||
![]() ![]() | |||
![]() ![]() ![]() | cvd-questionnaire-options: pa-moderate-daily (30-60 minutes moderate activity daily) | ||
![]() ![]() ![]() | 24.5 | ||
![]() ![]() | |||
![]() ![]() ![]() | 2026-01-15T11:00:00Z | ||
![]() ![]() ![]() | 2.4 | ||
![]() ![]() ![]() | true | ||
![]() ![]() ![]() | 126 | ||
![]() ![]() ![]() | 78 | ||
![]() ![]() ![]() | true | ||
![]() ![]() ![]() | true | ||
![]() ![]() ![]() | 178 | ||
![]() ![]() ![]() | 85 | ||
![]() ![]() ![]() | 26.8 | ||
![]() ![]() ![]() | Patient adheres to statin therapy; BP self-monitoring stable. | ||
Lithuanian
Generated Narrative: QuestionnaireResponse questionnaireresponse-cvd-prevention-plan-example
Language: en
| LinkID | Text | Definition | Answer |
|---|---|---|---|
![]() | Questionnaire:Plan of cardiovascular disease prevention measures and achievement evaluation | ||
![]() ![]() | |||
![]() ![]() ![]() | 2025-10-31T10:00:00+02:00 | ||
![]() ![]() ![]() | cvd-questionnaire-options: cvd-rg-very-large (Very large) | ||
![]() ![]() ![]() | cvd-questionnaire-options: ldl-target-18 (<1.8 mmol/l) | ||
![]() ![]() ![]() | |||
![]() ![]() ![]() | cvd-questionnaire-options: cessation-behavior (Behavior change tools) | ||
![]() ![]() | |||
![]() ![]() ![]() | cvd-questionnaire-options: pa-moderate-daily (30-60 minutes moderate activity daily) | ||
![]() ![]() ![]() | 24.5 | ||
![]() ![]() | |||
![]() ![]() ![]() | 2026-01-15T11:00:00Z | ||
![]() ![]() ![]() | 2.4 | ||
![]() ![]() ![]() | true | ||
![]() ![]() ![]() | 126 | ||
![]() ![]() ![]() | 78 | ||
![]() ![]() ![]() | true | ||
![]() ![]() ![]() | true | ||
![]() ![]() ![]() | 178 | ||
![]() ![]() ![]() | 85 | ||
![]() ![]() ![]() | 26.8 | ||
![]() ![]() ![]() | Patient adheres to statin therapy; BP self-monitoring stable. | ||
{
"resourceType": "QuestionnaireResponse",
"id": "questionnaireresponse-cvd-prevention-plan-example",
"language": "en",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"questionnaire": "https://hl7.lt/fhir/cvd/Questionnaire/cvd-prevention-plan",
"status": "completed",
"subject": {
"reference": "Patient/patient-male-example"
},
"authored": "2026-01-15T11:00:00Z",
"author": {
"reference": "Practitioner/practitioner-example"
},
"item": [
{
"linkId": "grp-plan-header",
"item": [
{
"linkId": "plan-created-datetime",
"answer": [
{
"valueDateTime": "2025-10-31T10:00:00+02:00"
}
]
},
{
"linkId": "plan-risk-group",
"answer": [
{
"valueCoding": {
"system": "https://hl7.lt/fhir/cvd/CodeSystem/cvd-questionnaire-options",
"code": "cvd-rg-very-large",
"display": "Very large"
}
}
]
},
{
"linkId": "plan-target-ldl",
"answer": [
{
"valueCoding": {
"system": "https://hl7.lt/fhir/cvd/CodeSystem/cvd-questionnaire-options",
"code": "ldl-target-18",
"display": "<1.8 mmol/l"
}
}
]
},
{
"linkId": "plan-target-bp"
},
{
"linkId": "plan-smoking-cessation",
"answer": [
{
"valueCoding": {
"system": "https://hl7.lt/fhir/cvd/CodeSystem/cvd-questionnaire-options",
"code": "cessation-behavior",
"display": "Behavior change tools"
}
}
]
}
]
},
{
"linkId": "grp-plan-lifestyle",
"item": [
{
"linkId": "plan-physical-activity",
"answer": [
{
"valueCoding": {
"system": "https://hl7.lt/fhir/cvd/CodeSystem/cvd-questionnaire-options",
"code": "pa-moderate-daily",
"display": "30-60 minutes moderate activity daily"
}
}
]
},
{
"linkId": "plan-target-bmi",
"answer": [
{
"valueDecimal": 24.5
}
]
}
]
},
{
"linkId": "grp-achievement",
"item": [
{
"linkId": "achievement-datetime",
"answer": [
{
"valueDateTime": "2026-01-15T11:00:00Z"
}
]
},
{
"linkId": "achievement-ldl-mmol",
"answer": [
{
"valueDecimal": 2.4
}
]
},
{
"linkId": "achievement-ldl-target-met",
"answer": [
{
"valueBoolean": true
}
]
},
{
"linkId": "achievement-bp-systolic",
"answer": [
{
"valueDecimal": 126
}
]
},
{
"linkId": "achievement-bp-diastolic",
"answer": [
{
"valueDecimal": 78
}
]
},
{
"linkId": "achievement-bp-target-met",
"answer": [
{
"valueBoolean": true
}
]
},
{
"linkId": "achievement-smoking-quit",
"answer": [
{
"valueBoolean": true
}
]
},
{
"linkId": "achievement-height-cm",
"answer": [
{
"valueDecimal": 178
}
]
},
{
"linkId": "achievement-weight-kg",
"answer": [
{
"valueDecimal": 85
}
]
},
{
"linkId": "achievement-bmi",
"answer": [
{
"valueDecimal": 26.8
}
]
},
{
"linkId": "achievement-comments",
"answer": [
{
"valueString": "Patient adheres to statin therapy; BP self-monitoring stable."
}
]
}
]
}
]
}